Document Detail

Assessment of effects of two anti-hypertensive regimens on overall cardiovascular risk.
MedLine Citation:
PMID:  7783099     Owner:  NLM     Status:  MEDLINE    
Anti-hypertensive drugs differ in their effects on other cardiovascular risk factors. To date there have been few attempts to quantitate the impact of such differences. Twenty five unmedicated patients with primary hypertension were randomised to initial therapy with either the calcium antagonist, felodipine, or a diuretic and doses titrated to achieve similar levels of blood pressure (BP). Second drugs were added if needed (metoprolol and prazosin, respectively). The aim was to determine over 1 year whether similar anti-hypertensive effects were associated with differences in a multivariate index of overall cardiovascular risk. The target supine diastolic blood pressure (DBP) (85 mm Hg) required the second agent in four of 13 evaluable patients in the felodipine group and six of 10 in the diuretic group. There was a significant rise in serum cholesterol and a fall in serum potassium in the diuretic group, but not in the felodipine group. Cardiovascular risk scores were ranked in percentiles in relation to the age-matched general population. This score fell to a greater degree in felodipine patients particularly over the first 6 months, but remaining lower at 12 months. Left ventricular hypertrophy assessed by echocardiography, another measure of cardiovascular risk, was generally unchanged by either regimen. At equivalent blood pressure levels, the calcium antagonist-based regimen had a greater benefit on cardiovascular risk, particularly in the first 6 months of therapy. This method may be widely applicable in the assessment of anti-hypertensive therapy.
G L Jennings; K Sudhir; E Laufer; P Korner; C Reid
Related Documents :
8205459 - Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary...
6545039 - Hypertension in elderly people in a swedish primary care district.
22327699 - Intraventricular cooling during csf infusion studies.
25319269 - Ediacaran 2,500-km-long synchronous deep continental subduction in the west gondwana or...
20660819 - Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ...
16268799 - Increased plasma n-terminal pro-b-type natriuretic peptide and markers of inflammation ...
20681149 - Interactions of xylazine and acepromazine with oxytocin and the effects of these intera...
10149179 - Biliary lithotripsy can be enhanced with proper ultrasound probe position.
7056959 - Pediatric aspects of essential hypertension.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of human hypertension     Volume:  9     ISSN:  0950-9240     ISO Abbreviation:  J Hum Hypertens     Publication Date:  1995 Mar 
Date Detail:
Created Date:  1995-07-17     Completed Date:  1995-07-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  181-6     Citation Subset:  IM    
Alfred and Baker Medical Unit, Baker Medical Research Institute, Prahan, Melbourne, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure / drug effects
Cardiovascular Diseases / etiology,  prevention & control*
Cholesterol / blood
Diuretics / administration & dosage*
Drug Therapy, Combination
Felodipine / administration & dosage*
Hypertension / complications,  drug therapy*,  physiopathology
Hypertrophy, Left Ventricular / prevention & control
Metoprolol / administration & dosage*
Middle Aged
Prazosin / administration & dosage,  pharmacology*
Risk Factors
Reg. No./Substance:
0/Diuretics; 19216-56-9/Prazosin; 37350-58-6/Metoprolol; 57-88-5/Cholesterol; 72509-76-3/Felodipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an un...
Next Document:  Intrarenal production of dopamine and natriuresis following DOPA and saline infusions in healthy hum...